Jennifer Atlas is an Oncology physician affiliated with Levine Cancer Institute. OpenAlex indexes 17 publications with 506 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1021 Morehead Medical Dr
Ste A
Charlotte, NC 282042990
Telephone
980-442-2000Registry record last updated 15 Jul 2024.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20253 payments
- Regeneron Pharmaceuticals, Inc.Program year20254 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
32.2%Aromatase Inhibitor10.3%Anastrozole52%Letrozole48%Part D<11 patientsEstrogen Agonist/Antagonist9.3%Tamoxifen Citrate100%Part D≥11 patients+ 3 more classes in this area
Hormonal (systemic)
29.1%l-Thyroxine29.1%Levothyroxine Sodium100%Part D≥44 patientsMetabolism & gastrointestinal
13.6%Corticosteroid5.8%Prednisone100%Part D≥16 patientsSerotonin-3 Receptor Antagonist5%Ondansetron Hcl100%Part D≥19 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety of planned dental extractions immediately after radiation therapy: DEXPoRT study
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
2025 - Safety of Planned Dental Extractions Immediately after Radiation Therapy: First Report of a Prospective Observational Study
International Journal of Radiation Oncology*Biology*Physics
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Voorhees, MD
Levine Cancer Institute
Stuart Burri, MD
Levine Cancer Institute
Benjamin Moeller, MD, PhD
Levine Cancer Institute
Jubilee Brown, MD
Levine Cancer Institute
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”